52% Healthcare Providers Choose CGM Tech Over Meds for Type 2 Diabetes: Reports
Dexcom's State of Type 2 Report highlights CGMs as pivotal for managing diabetes. Over half of surveyed providers favor CGM tech over new medications.
According to the Dexcom report, 52% of healthcare providers favored CGM technology over medications for managing Type 2 diabetes.
Dexcom, an American healthcare company, has recently launched a report titled “Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East”.
The study surveyed 2,500 participants, including individuals with type 2 diabetes and healthcare professionals from Germany, Italy, the Netherlands, Saudi Arabia, Spain, and the UK.
The findings provide insights into care approaches and the perception of diabetes technology within the type 2 diabetes community.
According to the company, the report serves as a call to action for policymakers, emphasizing the advantages of Continuous Glucose Monitoring (CGM) technology for a significant population of type 2 diabetics in the surveyed regions.
The survey findings indicated that 52% of healthcare providers see CGMs and their real-time blood sugar readings as pivotal for diabetes management over the next decade, compared to 38% who prioritized medications.
“With policymakers increasingly focused on digital transformation in healthcare, now is the time to push for greater investment in CGM technology as a core component of Type 2 management,” said Adrian Gut, Dexcom’s senior director of international access, advocacy, and value.
Dexcom highlighted that 77% of people with type 2 diabetes who had not used CGM believed it would improve their lives, while 93% of those already using CGM affirmed its positive impact.
Approximately half of the surveyed healthcare providers believe CGMs should become the standard of care, regardless of a patient’s insulin usage.
“Enhancing CGM accessibility is crucial to tackling the Type 2 crisis. By ensuring equitable access to this life-changing technology, we can empower people with Type 2 to take control of their diabetes management, improve their quality of life, and reduce complications,” Gut added.
Type 2 diabetes is a chronic medical condition affecting how the body processes blood sugar (glucose). The IDF Diabetes Atlas (2021) reports that 10.5% of the adult population (20-79 years) has diabetes. Over 90% of people with diabetes have type 2 diabetes, which is driven by socio-economic, demographic, environmental, and genetic factors.
